|
Post by dreamboatcruise on Jan 26, 2018 17:32:17 GMT -5
It's 2018. A new dawn... Oprah has spoken. If we're going to objectify sexy Afrezza spokespeople we need both men and women I nominate Spiro. 🤣 (in a Speedo) Hopefully he still has his trademark hat to class it up a bit.
|
|
|
Post by dreamboatcruise on Jan 26, 2018 17:30:40 GMT -5
We are not ready to graduate from $2s. Yesterday was most likely options related with the help of 29K watchers. Takeaways for me: 1. No news yet 2. Shorts are still in control 3. I did not add above 3 because I know better 4. MK is a mere human and should stop giving trading advice before he looses what's left of his credibility But rumors are that he knows something and anyone that says otherwise is full of baloney.
|
|
|
Post by dreamboatcruise on Jan 26, 2018 17:08:43 GMT -5
Any idea as to what exactly happened yesterday, today? There wasn't any social media stuff to influence. Was it an algo trade that went out of control? Or, may be someone knew what is/will happen, as that Linkedin guy said? Nice drop today to buy. But, I'm scared of this stock! Like an idiot, I bought at 5.xx when it was going up last time. I really thought the label change was the *REAL* game changer. Stat is another big thing, but is not due until June (2 quarters!!). I don't think MNKD has enough cash to last 2 qtrs - right? Needs cash before Jun. * Cant dilute at $3. * A partner/insurance deal? Didn't someone say insurance change is ruled out for 2018? Also, as someone said China partner, and dilute? Any idea - peppy , and other knowledgeable folks? Thanks! Some formularies are updated mid year, so I think "ruled out" is inaccurate. How much change we might expect, I wouldn't hazard a guess on. At current revenue levels they do not have money for 2 qtrs. Why would you suppose they "can't" dilute at $3?
|
|
|
Post by dreamboatcruise on Jan 26, 2018 16:33:12 GMT -5
When a company's shares rocket on huge volume like MNKD's did yesterday, isn't it usual for the company to issue a statement? Even if the statement is 'I know nothing'? Sort of weird to hear absolutely nothing. youtu.be/UmzsWxPLIOoIf you're on an airplane and you have lurching up and down, the pilot will come on to reassure it's just turbulence. If you're on a roller coaster, park management usually doesn't feel obligated to explain the ups and downs with a broadcast announcement. Did you think this was Jet Blue service to Newark when you got in line?
|
|
|
Post by dreamboatcruise on Jan 26, 2018 16:29:40 GMT -5
peppy - should we still look to the left? I think price went down because we didn't see more Laura K pics ... Just mytakeonit It's 2018. A new dawn... Oprah has spoken. If we're going to objectify sexy Afrezza spokespeople we need both men and women
|
|
|
Post by dreamboatcruise on Jan 26, 2018 16:23:29 GMT -5
I'd certainly guess they point out we'll only have enough cash for a fairly short period of time... because that will likely be true. right around June when the stat study comes out. is there a catch 22 here dream boat? I am asking. Because we need catch 22. Are the pharmacy purchasing managers/health insurance required to cover a superior product? Do you or anyone here know (Matt) are there requirements for the PBM/health insurance to offer products in the same insulin category that are found superior? Seems they'll need to raise money before STAT is public. I think a very large offering wouldn't be successful right now, and if we are going to have good news with STAT and possibly mid year formulary improvement, it might not even make sense to try to do a large offering now. I'm glad I don't have to make that decision, however. It could seem smartest to do a smaller raise now and wait for facts on the ground to look better, but then there could be some big broader market shaking event that makes an offering difficult to do when they would need it. It's an uncomfortable place to be having such a short cash runway. With my businesses I always tried to keep a one year runway between cash and order backlog, and would have felt very insecure if that were no more than 4 months. I don't think there is any clear law that says an insurance company has to cover something that is "superior" because there really isn't a clear definition of what that would mean within any given drug category. There could be a whole myriad of metrics that are end points of clinical trials. Superiority on which of those and how much of an improvement would trigger a mandate for coverage would be something very difficult to determine. But even with lack of a clear law, patients could put a lot of pressure on insurance if there were trials showing meaningful superiority in some metric(s) that is generally accepted as clinically important. Though putting patients through "step therapy" to see if they respond well on cheaper things still might be hard to get rid of... at least until ADA changes guidelines. Rather than "superior" I think the legal standard would be "medically necessary," but that too has no clear definition... and different states may have nuances about mandatory coverage. You see law suits by patients all the time over whether treatments should be considered medically necessary. A cancer treatment that keeps someone alive for 6 months on average vs 5 months is clearly superior, but if it costs half a million for that extra month is an insurer obligated to pay for it... etc. Then there is the whole issue of the convoluted rebate system, which may mean apparent cost savings aren't necessarily the big driver on formulary coverage. [My general thoughts on your question based on what I know, but please take with grain of salt. If I really knew this stuff I'd be rich by now.]
|
|
|
Post by dreamboatcruise on Jan 26, 2018 15:46:19 GMT -5
I sold half of my (small stake) at 3.82 for a profit late yesterday, so today I feel (so far) like a stable genius. I'm only kicking myself because I almost purchased additional shares at the start of the week, feeling it was about time for another 'pump and dump' move. But I wasn't willing to invest based on a 'feeling'.
But that's what MNKD is all about. I, I'm hooked on a feelin' High on believin' I got it bad for MNKD, but I don't need a cure I'll just stay addicted and hope I can endure www.youtube.com/watch?v=O2lEO7vaozo
|
|
|
Post by dreamboatcruise on Jan 26, 2018 14:10:56 GMT -5
Only if you present it in a gold-pressed-latinum chalice. In that case, please fill said goblet with MNKDrano-wine. Drink slowly from this and don't take big gulps.....It is perfectly set up for the drano wine.
How'd you get passed the Secret Service to get into Trump Tower?
|
|
|
Post by dreamboatcruise on Jan 26, 2018 14:06:09 GMT -5
Love your references. I kind of figured this would be the case, as it's essentially the same statement w/ most companies other than Alphabet. She would love to try it but she has AmBetter; which does not currently cover Afrezza. Plus, as a type 1; Afrezza is essentially only supplemental. She wouldn't be able to get off of her long lasting insulin injections/pod system; so it really doesn't offer her anything special, at the moment. This said, she would give it a shot if AmBetter would cover it; just for the novelty and in hopes that MNKD expands their platform into longer lasting insulin, down the line. Not sure they could do it via inhalation though.Regardless; as to your question: I am a fool, that is why. HAHA! But, just looking at charts and thinking about timelines. Afrezza has been on market for 3 years now. It's due to either boom, or bust. Much like MNKD; near it's all time low and has been for over 2 years. It's due to either pump, or die entirely; in next 18 months. I tend to expect Afrezza itself is going to make it, to new avenues. Whether or not MNKD champion's it's baby, or goes out of business to have the concept tackled by another, I have no clue. But I do anticipate a true alternative to injections for diabetics becoming a staple, and common, sooner than later. I jumped on the ship because, honestly, it had been years since I'd read of the product; I see all-time-low creating a 50/50 shot at either profit or loss; I believe in the industry and potential of the product. All this said, here is how foolish I am! 3 months ago, I was investing in Crypto. 1 month ago, I determined 100% of crypto is price fixed, casino equivalent pseudo investing. I might think MNKD is a disaster 40 days from now. My hope-gut pushes me more toward, MNKD stabilizing and the difference in a $1 per share price and a $3 per share price, becoming negligible, during next 2 years. It would have to be a very differently formulated long acting to work inhaled. The current long acting work by delaying the progression into the blood stream. Having an insulin hang around in the lungs doesn't sound terribly good idea to me, so inhaled long acting would likely need to be some form that got into the blood and only gradually converted from an inactive state to the active form of insulin. That doesn't currently exist. Perhaps suggest to your SO to look into Tresiba and Afrezza. It seems some are getting pretty darn good results with that combo and allowing them to get rid of the pump with once daily injection. Though I gather peoples' views about desirability of wearing a pump are all over the map.
|
|
|
Post by dreamboatcruise on Jan 26, 2018 13:27:08 GMT -5
Before I venture an answer to your last question... explain why you think it likely that good news comes on 29th. MNKD has for years done these sorts of conferences and I don't recall a single time where it was the venue to announce something meaningful. At the conference I expect praising jump in revenue (from price hike), some references to negotiating better insurance coverage, work continuing on finding overseas partners and a teasing mention of RLS (we can never see that Mike winks every time he mentions RLS) Oh, and very quick mumbling under his breath about missing guidance last period. Hmm... what has my experience been so far as MNKD investor... well, there was this time I had a laparoscopic operation that went horribly wrong... or there was when I got caught in a rock slide in the mountains. Can't quite pick the perfect analogy. Is your SO wanting to try Afrezza? "Before I venture an answer to your last question... explain why you think it likely that good news comes on 29th." Geezus, DBC, give the new guy a break! The answer to your question is revealed in his post - in the very first sentence, for goodness sake. Grand man, hang in there, it's going to be a bumpy ride! It was in jest. I even just edited to add in another little winky... oops, I mean perfectly normal size winky
|
|
|
Post by dreamboatcruise on Jan 26, 2018 13:11:40 GMT -5
Bots generating hit pieces, tool bags reporting fake news all when the stock is retracing and the shorts have dug in after yesterday's explosion. Not hard to have happen considering nearly half the float is short, duh. Funny how yesterday nobody could explain the run up (all theories here and everywhere else) but, today...everyone or every bot has the answer. Bwaaahaaahaa. Nothing happening. Shuffling off for the weekend. By the way, once we have the announcement for the secondary and we have the cash, they'll still say we don't have the cash. Mark it! Have a great weekend -best regards. I'd certainly guess they point out we'll only have enough cash for a fairly short period of time... because that will likely be true.
|
|
|
Post by dreamboatcruise on Jan 26, 2018 13:06:32 GMT -5
Ok, I got in 2.65 on Wed so I made some profit so far... What do guys think about today's high and close? Also what do you think about next week's performance? Thank you:)! Next weeks performance will be Shakespeare... full of sound and fury, signifying nothing. Out, out, brief candle.
|
|
|
Post by dreamboatcruise on Jan 26, 2018 12:58:35 GMT -5
So guys I am brand new to MNKD investing. I had read about their inhalable insulin being developed back in 2011. My significant other is a type-1. We thought it fell by the wayside and I've just discovered w/ my e-trade research. Hah! My question to you kind folk is; what has your experience with MNKD been thus far, as investors? Are you personally leaning towards MNKD sinking, or swimming; in the next 24 months? Do you like them as a company? See any major, glaring flaws, in their ability to stabilize and grow? I bought in, today; 2/3 from top of recent bubble... Major booboo in most cases; but I expect likely good news announced on the 29th; and long term projection of price surpassing $4 before end of 2018. Am I a fool? BTW, kudos to the Klingon and Romulan reference above. Everyone knows the Klingon's will never stand for double dealing by MNKD. They will squash any Romulan petaQ's, for the sniveling, conniving dogs that they are; and maybe even incite mutiny on MNKD. Qapla! Before I venture an answer to your last question ... explain why you think it likely that good news comes on 29th. MNKD has for years done these sorts of conferences and I don't recall a single time where it was the venue to announce something meaningful. At the conference I expect praising jump in revenue (from price hike), some references to negotiating better insurance coverage, work continuing on finding overseas partners and a teasing mention of RLS (we can never see that Mike winks every time he mentions RLS) Oh, and very quick mumbling under his breath about missing guidance last period. Hmm... what has my experience been so far as MNKD investor... well, there was this time I had a laparoscopic operation that went horribly wrong... or there was when I got caught in a rock slide in the mountains. Can't quite pick the perfect analogy. Is your SO wanting to try Afrezza?
|
|
|
Post by dreamboatcruise on Jan 26, 2018 1:47:32 GMT -5
How much More is Mannkind Corporation worth since the January Options expiration a couple days ago? Do we include all of the shares or just the shares issued? Someone help me with the math; my abacus is broken. Hopefully not all of the authorized shares will be issued, but I imagine if people are doing worst case analysis they might consider hitting the authorized limit again. It does seem highly likely we will see some additional dilution. I think anyone that tells you they can predict how much is simply blowing smoke.
|
|
|
Post by dreamboatcruise on Jan 25, 2018 20:10:22 GMT -5
A substantial increase in the script count tomorrow and one announcement will put a lot of minds at ease. C'mon Castanga, one announcement please! In two part harmony... All your dreams are on their way See how they shine Like a bridge over troubled water Mike will ease your mind Like a bridge over troubled water... Fingers crossed for tomorrow
|
|